Companies & Industry »Company News
Cipla Ltd - Company News

BSE   16 Aug 18 | 01:25 PM

649.45 7.5 (1.17%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 500087
Face Value: 2

NSE   16 Aug 18 | 01:14 PM

650.00 7.25 (1.13%)
Mkt Price (Rs)   Chg Rs (Chg %)
1 Week : Rs 619.25 (4.88%)
1 Month : Rs 621.40 (4.51%)
1 Year : Rs 590.20 (10.04%)
change companytradenow

  • 17 Nov 16
    01:53 AM
    Over the next six months, dug maker Cipla plans to increase its product filings in the US and launch the generic version of GlaxoSmithKline's (GSK) blockbuster inhaler Seretide in the UK market.
  • 13 Oct 16
    09:25 AM
    Cipla was  trading higher by 3% to Rs 596 on the BSE in early morning trade after the drug maker on Wednesday said that it has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its Indore facility
  • 12 Oct 16
    06:44 PM
    Cipla Limited on Wednesday announced that it has received Establishment Inspection Report (EIR) from the US FDA for its Indore facility indicating formal closure of the US FDA inspection conducted in July/August, 2015.The FDA had made adverse
  • 30 Sep 16
    01:05 PM
    Cipla has dipped 6.5% to Rs 562 on the BSE, its sharpest intra-day fall in past three months, on media reports that the United States Food and Drug Administration (USFDA) inspected the company’s Goa facility.
  • 29 Sep 16
    04:02 PM
    Drug companies are facing a tough environment due to the government bringing more products under the price control policy and tightening of registration procedure that has impacted time to market newer products, Cipla Chairman YK Hamied has said.
  • 16 Aug 16
    12:53 PM
    Cipla has surged 5% to Rs 544 on the National Stock Exchange (NSE) after the company announced an improvement of around 200 basis points in base business EBITDA (earnings before interest, depreciation and taxes) margin.
  • 09 Jul 16
    12:29 AM
    An employee works at the reception area of Cipla at its headquarters in MumbaiCipla is investing 1.3 billion South African rand (about Rs 600 crore ) in a biotechnology plant in South Africa as it aims to make cancer drugs affordable and grow presence in
  • 25 May 16
    04:17 PM
    Cipla surprised the market with a sharp drop of 69% in its quarterly net profit, much below the expectations of analysts. The stock touched a new 52-week low, falling over 7% but recovered some ground later in the day.
Widgets Magazine


Company Price Gain (%)
Sun Pharma.Inds.612.851.86
Axis Bank628.801.70
ICICI Bank336.651.31
Hero Motocorp3,298.951.10
Widgets Magazine


Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine